🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Nephrotic Syndrome

A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood. NCT04207580n/a48 sites📍 Agen📍 Amiens📍 Auxerre University Hospital, Limoges · Tests: Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome, A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) NCT05583942NA2 sites📍 New Hyde Park📍 Philadelphia Northwell Health · Tests: trascutaneous auricular vagus nerve stimulation, Sham device China Kidney Patient Trials Network NCT05036850n/a1 site📍 Beijing George (Beijing) Clinical Research Co. Ltd. Diuretic Tuner Clinical Decision Support NCT04759274NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Diuretic Tuner From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP NCT04174066n/a2 sites📍 Nice📍 Paris Centre Hospitalier Universitaire de Nice · Tests: blood sample, tissue sample, excreta CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease NCT07305116Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: UCAR T-cell Nephrotic Syndrome Study Network NCT01209000n/a44 sites📍 Los Angeles📍 Palo Alto📍 San Francisco University of Michigan · Tests: Kidney Biopsy Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. NCT05505500n/a1 site📍 Ann Arbor University of Michigan · Tests: Interview A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD) NCT07710157Phase 26 sites📍 Graz📍 Innsbruck📍 Vienna Medical University Innsbruck · Tests: Obinutuzumab Injection, Predniso(lo)ne Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease NCT05650619n/a1 site📍 Ann Arbor University of Michigan · Tests: Biospecimen collection, Data collection Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis NCT07010250n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris taVNS for FRNS in Children NCT05588063NA2 sites📍 New Hyde Park📍 Philadelphia Northwell Health · Tests: Transcutaneous auricular vagus nerve stimulation, Sham device Dupilumab Therapy in Nephrotic Syndrome in Children NCT07091175Phase 22 sites📍 Singapore📍 Singapore National University Hospital, Singapore · Tests: Dupilumab, Placebo, Co-intervention of Prednisolone wean during randomised controlled phase, Dupilumab open label exten… An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site📍 Bethesda National Human Genome Research Institute (NHGRI) · Tests: ManNAc Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases NCT07614477Phase 22 sites📍 Beijing📍 Tianjin Everest Medicines (China) Co.,Ltd. · Tests: EVER001 Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome NCT06334692n/a1 site📍 Ranica Mario Negri Institute for Pharmacological Research · Tests: In-house ELISA, and ELISA kits from "DBA Italy" (Abbexa). The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome NCT07206537NA1 site📍 Cairo Ain Shams University · Tests: Vitamin K 2 Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease NCT07507201EARLY Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: UCAR T-cell A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis NCT07499700Phase 2, Phase 31 site📍 Beijing Bio-Thera Solutions · Tests: BAT4406F, Placebos Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS NCT06553898Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: anti-BCMA/CD70 CAR-T cells KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis NCT03929887n/a6 sites📍 Chuncheon📍 Daegu📍 Seoul Seoul National University Hospital · Tests: Kidney Biopsy A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria NCT04456816Phase 21 site📍 Aarhus SynAct Pharma Aps · Tests: 100 mg AP1189, Placebo Immune System Related Kidney Disease NCT00001979n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Steroid Diabetes in Patients With Kidney Disease NCT06161701n/a1 site📍 Hangzhou Zhejiang Provincial People's Hospital · Tests: no intervention Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) NCT06669949n/a1 site📍 San Francisco University of California, San Francisco · Tests: no intervention Ketoanalogues for Muscle Mass Loss in Nephrotic Syndrome NCT05716880Phase 31 site📍 Warsaw Military Institute od Medicine National Research Institute · Tests: Ketosteril, Medium Protein Diet (MPD) A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines NCT07561957NA2 sites📍 Dublin📍 Dublin St. James's Hospital, Ireland · Tests: Use of an electronic digital Application SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome NCT07214818Phase 2, Phase 31 site📍 Al Mansurah Mansoura University · Tests: Dapagliflozin, Empagliflozin, Standard Therapy The Role of Proprotein-convertase-subtilisin/Kexin-type 9 in Kidney Damage in Nephrotic Syndrom NCT06373913n/a1 site📍 Kolding Kolding Sygehus ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank NCT06162546n/a1 site📍 Vienna Christoph Aufricht · Tests: Registry
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy